AZA Combined With RCHOP in P53-mutated DLBCL.

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
AZA Combined With RCHOP in P53-mutated DLBCL.	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, histiocytosis, interdigitating dendritic cell sarcoma, lymphatic system disorder, malignant histiocytosis, neoplasm	Recruiting	Phase 2	2025-02-19		NCT06158399

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chinese Academy of Medical Sciences	36
Jiangsu Provincial People's Hospital	19
Shanxi Province Cancer Hospital	43
Sun Yat-sen University	606
The First Affiliated Hospital of Xiamen University	107

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Bing Xu	Xiamen	China	7

Clinical trials